Trinity Biotech (TRIB) Intangibles (2013 - 2025)

Trinity Biotech (TRIB) has reported Intangibles for 12 consecutive years, with $57.0 million the latest figure, recorded in Q4 2025.

• Quarterly Intangibles rose 10.99% year-over-year to $57.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $57.0 million (up 10.99% YoY) and the FY2025 annual result came in at $57.0 million, up 10.99% from the prior year.
• Intangibles grew to $57.0 million in Q4 2025 per TRIB's latest filing, from $55.9 million in the prior quarter.
• Over the last five years, Intangibles for TRIB reached as high as $221.9 million in Q4 2023 and fell as low as $35.3 million in Q4 2022.
• A 5-year average of $67.2 million and a median of $46.6 million in 2024 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2023 — Intangibles jumped 529.18% — and 2024, when it slumped 76.86%.
• Year by year, Intangibles stood at $36.0 million in 2021, then declined by 1.98% to $35.3 million in 2022, then soared by 529.18% to $221.9 million in 2023, then sank by 76.86% to $51.3 million in 2024, then rose by 10.99% to $57.0 million in 2025.
• According to Business Quant data, Intangibles over the past three periods registered $57.0 million, $55.9 million, and $51.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.